Moreover, mechanism dissection suggested the CYP19/estrogen/G protein-coupled estrogen receptor (GPER)/Gαi signaling pathway may be involved in the regulation of stromal cell proliferation and prostatic fibrosis, which may function to accelerate the clinical progression of patients with BPH. This evidence concerns the gene CYP19A1 and benign prostatic hyperplasia.